As regular readers of the other properties well know, I’ve been a long-term proponent (five plus years) of Moderna, and since very early 2020, an ardent holder of Moderna (in, at $35/ish a share).
And regular readers also know that I’ve repeatedly said the vaccine (when approved), will be subjected to simply staggering public policy (and in some geographies, direct governmental) pressures… to be priced affordably for the vast bulk of the resource constrained world.
So, I might say that this is the moment that the steak is. . . sizzling pretty loudly. But still sizzling… not yet served.
And, so… I’ve sold three-quarters of my holdings on the NASDAQ, just this morning, at about an average of $128.25 a share.
I still very firmly believe in this well-run and brilliantly-innovative life sciences company… but it is time to take some risk off the table.
I still foresee a very difficult pandemic winter of ’20-’21… so stocking up (on cold hard cash) is not a bad idea. It preserves flexibility. And while I will continue to hold the remaining 25 per cent, I may very well buy back in (in size), if/when Moderna sees a 30 per cent or more (temporary) downward correction. That would be a pure buying opportunity. Now you know.
Onward, grinning — ever grinning… going to see what’s on sale, online here on Black Friday.
नमस्ते
Powerline Lies... 